Scott Scott Franklin
Scott Scott Franklin (R-FL) bought $1K-$15K of $ACN (Accenture plc Class A Ordinary Shares (ACN) [ST]) on Aug 7, 2024, part of 35 transactions in this filing (31 buys, 4 sells).
HillSignal flagged 5 timing concerns on this filing — trades that line up closely with related legislative or contract activity.
Companies in this filing · 31
Price Movement Since Trade
How the largest positions have moved from the trade date to the most recent close.
Showing the 6 largest positions. See every transaction in the table below.
Sign Up to See More
See the full trade breakdown, suspicious timing flags, and how this filing connects to active legislation.
Get Free Access →Suspicious Timing Detected
5 flagsRepresentative Franklin bought $1,001 - $15,000 in $AMGN on 2024-08-07, 245 days before the BRAIN Act (HR2767) was introduced, a bill aiming to increase research for brain tumor treatment.
Representative Franklin bought $1,001 - $15,000 in $MRK on 2024-08-07, 245 days before the BRAIN Act (HR2767) was introduced, a bill aiming to increase research for brain tumor treatment.
Representative Franklin bought $1,001 - $15,000 in $JPM on 2024-08-07, 246 days before the Federal Home Loan Banks' Mission Activities Act (S1439) was introduced, which expands FHLB support for affordable housing.
These flags identify timing coincidences between stock trades and legislative activity. They do not imply wrongdoing. Click any bill number or ticker to see the full analysis.
Share This Filing
All Transactions
| Type | Ticker | Asset | Amount | Trade Price | Current | Change | Date |
|---|---|---|---|---|---|---|---|
| BUY | $ACN | Accenture plc Class A Ordinary Shares (ACN) [ST] | $1K-$15K | — | $178.43 | — | Aug 7, 2024 |
| BUY | $APD | Air Products and Chemicals, Inc. Common Stock (APD) [ST] | $1K-$15K | $277.44 | — | — | Aug 7, 2024 |
| BUY | $GOOG | Alphabet Inc. - Class C Capital Stock (GOOG) [ST] | $1K-$15K | — | — | — | Aug 7, 2024 |
| BUY | $AMGN | Amgen Inc. - Common Stock (AMGN) [ST] | $1K-$15K | — | — | — | Aug 7, 2024 |
| BUY | $AAPL | Apple Inc. - Common Stock (AAPL) [ST] | $1K-$15K | $209.82 | $271.06 | +29.2% | Aug 7, 2024 |
| BUY | $ADP | Automatic Data Processing, Inc. - Common Stock (ADP) [ST] | $1K-$15K | — | $196.53 | — | Sep 25, 2024 |
| BUY | $BRK.B | Berkshire Hathaway Inc. New Common Stock (BRK.B) [ST] | $1K-$15K | — | — | — | Aug 7, 2024 |
| BUY | $CB | Chubb Limited Common Stock (CB) [ST] | $1K-$15K | — | — | — | Aug 7, 2024 |
| BUY | $CMCSA | Comcast Corporation - Class A Common Stock (CMCSA) [ST] | $1K-$15K | — | — | — | Aug 7, 2024 |
| BUY | $COST | Costco Wholesale Corporation - Common Stock (COST) [ST] | $1K-$15K | $810.30 | $1,011.15 | +24.8% | Aug 7, 2024 |
Connected Legislative Activity
10 signalsThese bills and contracts share tickers or sectors with this filing's trades.
Expanded Student Saver’s Tax Credit Act
HR2852 (Expanded Student Saver's Tax Credit Act) is an early-stage bill that would allow full-time students to claim the Saver's Credit and later the Saver's Match. The bill has zero appropriated funding — it modifies eligibility rules only. With just 2 cosponsors and referral to the Ways and Means Committee, it faces a long legislative path. The market impact on financial sector stocks is negligible. No executive action from April 20, 2026 is relevant to this bill.
Protecting Employees and Retirees in Business Bankruptcies Act of 2025
S. 1381 (Protecting Employees and Retirees in Business Bankruptcies Act of 2025) is an early-stage Senate bill that would structurally increase bankruptcy costs for labor-intensive companies. For UAL and GM, the bill elevates employee and retiree claims in Chapter 11, raising bankruptcy risk premiums. At impact score 3, near-term market effects are minimal, but the structural risk is real if the bill advances through the Judiciary Committee.
Secure Space Act of 2025
The Secure Space Act of 2025 (HR2458) creates a protected domestic satellite market by barring FCC licenses to foreign entities of concern. Pure-play U.S. satellite operator IRDM is the clearest beneficiary, with a direct revenue tailwind from reduced competition. Incumbent carriers T, VZ, and TMUS face neutral near-term impact from supply constraints but gain long-term insulation for domestic satellite partnerships, with TMUS holding a relative advantage via its SpaceX/Starlink partnership. The bill passed the House on 2025-04-28 under suspension of the rules and awaits Senate action.
Dietary Guidelines Reform Act of 2025
The Dietary Guidelines Reform Act of 2025 (HR2326) extends the federal dietary guideline update cycle from 5 to 10 years, providing direct regulatory relief to large packaged food and beverage manufacturers by halving mandatory reformulation frequency. The bill is early-stage (referred to subcommittee) with bipartisan cosponsors and an identical Senate companion, indicating moderate passage potential. Real market data shows consumer staples stocks have rallied 0.43% to 6.51% over the past 7 days, with $MDLZ leading at +6.51%.
Federal Home Loan Banks' Mission Activities Act
The Federal Home Loan Banks' Mission Activities Act (S.1439) is in early legislative stages (referred to committee). The bill structurally benefits community-focused banks by lowering their cost of funds through expanded FHLB membership and subsidized financing authorization, but the primary winners are small CDFIs and credit unions — not the large super-regionals like RF, HBAN, FITB, USB, and PNC. For these larger institutions, the bill is net neutral: they gain access to cheaper FHLB funding for community lending but face increased mandatory affordable housing program contributions and greater competition from newly eligible CDFIs. Current price action for all five tickers shows positive 30-day momentum (up 6-9%), but this is consistent with the broader financial sector rally and is not attributable to this early-stage bill. No real immediate market impact.
ABC Safe Drug Act
The ABC Safe Drug Act (S. 1407) is in early legislative stages, having been referred to the Senate Finance Committee. It phases in restrictions on federal health programs purchasing drugs with Chinese active ingredients by 2030 and provides temporary tax incentives for domestic pharmaceutical manufacturing. Major pharma stocks ($PFE, $MRK, $JNJ, $LLY, $AMGN) show mixed but broadly negative 7-day changes, reflecting sector headwinds rather than this nascent bill. No market-moving impact is imminent.
Food Secure Strikers Act of 2025
HR 2357, the Food Secure Strikers Act of 2025, is an early-stage bill with no near-term market impact. It has been referred to subcommittee, has no floor schedule, no companion bill passage in the Senate, and no authorized funding. Walmart and Kroger face negligible SNAP volume upside from this bill in its current state. The market data shows both stocks trading near their 52-week highs with positive 7-day and 30-day momentum unrelated to this legislation.
BRAIN Act
The BRAIN Act (HR2767) is an early-stage bill in the 119th Congress that authorizes no funding and has been referred to committee. Near-term market impact is negligible. The bill creates programmatic structures for brain tumor research, biospecimen transparency, and biomarker testing awareness, but actual market effects require future appropriations and bill text clarity. No publicly traded companies face material revenue exposure at this stage.
Climate Change Financial Risk Act of 2025
The Climate Change Financial Risk Act of 2025 (HR2823) would impose mandatory biennial climate risk capital evaluations and resolution plans on large U.S. banks. This creates direct compliance costs for JPMorgan, Bank of America, Citigroup, Goldman Sachs, and Morgan Stanley, while generating demand for consulting and IT services from Accenture and IBM. The bill is in early legislative stages with a companion bill in the Senate, but has low near-term passage probability given partisan dynamics and its early committee referral status.
Child and Dependent Care Tax Credit Enhancement Act of 2025
HR2994 is a bill to enhance and make partially refundable the Child and Dependent Care Tax Credit. It has been referred to the House Committee on Ways and Means with no further action. At this procedural stage, there is zero near-term market impact for any publicly traded company. Real market data shows Walmart at $128.01 (7-day -3.04%) and Target at $127.87 (7-day -1.77%) driven by other factors.
Other Filings by Scott Scott Franklin
Free — no credit card
Get the next Franklin trade the day it's disclosed
HillSignal tracks every Congressional stock filing and federal contract, scores its market impact with AI, and emails you the ones that matter — before they hit the news.
Weekly digest — the congressional activity that actually moved markets that week, in plain English. Free, one email.
Free forever plan · No credit card · Unsubscribe in one click
Want the live terminal too? Create a free account →
Data sourced from the U.S. House of Representatives Office of the Clerk Financial Disclosure system. Stock prices from Financial Modeling Prep. Suspicious timing flags identify coincidences between stock trades and legislative activity and do not imply any wrongdoing or illegal activity. This is not financial advice.